New Study for Treatment of Relapsed B-cell Lymphoma in Dogs

TANOVEA®-CA1 (rabacfosadine for injection) is a novel double prodrug that targets cancerous lymphoma cells and is the first FDA conditionally approved drug for the treatment of lymphoma in dogs. Previous studies have suggested that administration of rabacfosadine every 3 weeks can achieve … Keep Reading

My Dog has Lymphoma: What Do I Do Now?

My dog has lymphoma. It’s a sentence you never want to hear yourself speaking. Unfortunately, lymphoma is one of the most common cancers in dogs. Many owners will be faced with learning how to deal with that diagnosis and the … Keep Reading

How does TANOVEA®-CA1 work?

TANOVEA®-CA1 is the first lymphoma treatment for dogs that has been conditionally approved by the FDA. Targeting rapidly multiplying lymphoma cells, it mimics a DNA building block, preventing cells from dividing and ultimately causing them to die. The medication is … Keep Reading